v3.24.0.1
Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Class A
Common Stock
Class B
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total Stockholders’ Equity attributable to Purple Innovation,Inc.
Noncontrolling Interest
Total
Balance at Dec. 31, 2020 $ 6 $ 333,047 $ (265,856) $ 67,197 $ 344 $ 67,541
Balance (in Shares) at Dec. 31, 2020 63,914 536          
Net (loss) income 3,114 3,114 (166) 2,948
Stock-based compensation 3,366 3,366 3,366
Exchange of stock
Exchange of stock (in Shares) 88 (88)          
Exercise of warrants $ 1 64,426 64,427 64,427
Exercise of warrants (in Shares) 2,298            
Exercise of stock options 1,418 1,418 1,418
Exercise of stock options (in Shares) 171            
Tax receivable agreement liability (760) (760) (760)
Deferred income taxes 2,937 2,937 2,937
Accrued tax distributions (401) (401) (401)
Issuance of stock
Issuance of stock (in Shares) 22            
InnoHold indemnification payment 4,142 4,142 4,142
Impact of transactions affecting NCI (584) (584) 584
Balance at Dec. 31, 2021 $ 7 407,591 (262,742) 144,856 762 145,618
Balance (in Shares) at Dec. 31, 2021 66,493 448          
Net (loss) income (92,470) (92,470) (253) (92,723)
Issuance of stock upon underwritten offering, net of costs $ 1 92,865 92,866 92,866
Issuance of stock upon underwritten offering, net of costs (in Shares) 16,100            
Issuance of stock for acquisition $ 1 26,105 26,106 26,106
Issuance of stock for acquisition (in Shares) 8,613            
Issuance of stock under equity compensation plans
Issuance of stock under equity compensation plans (in Shares) 154            
Stock-based compensation 3,366 3,366 3,366
Exercise of stock options 166 166 166
Exercise of stock options (in Shares) 20            
Accrued tax distributions (228) (228) (228)
Impact of transactions affecting NCI (399) (399) 399
Balance at Dec. 31, 2022 $ 9 529,466 (355,212) 174,263 908 175,171
Balance (in Shares) at Dec. 31, 2022 91,380 448          
Net (loss) income (120,757) (120,757) (458) (121,215)
Proportional Representation Preferred Linked Stock redemption fee (105) (105) (105)
Issuance of stock upon underwritten offering, net of costs $ 2 56,997 56,999 56,999
Issuance of stock upon underwritten offering, net of costs (in Shares) 13,400            
Escrow shares cancelled in connection with Intellibed acquisition (118) (118) (118)
Escrow shares cancelled in connection with Intellibed acquisition (in Shares) (41)            
Issuance of stock under equity compensation plans
Issuance of stock under equity compensation plans (in Shares) 525            
Stock-based compensation 4,875 4,875 4,875
Exchange of stock
Exchange of stock (in Shares) 243 (243)          
Impact of transactions affecting NCI 265 265 (265)
Balance at Dec. 31, 2023 $ 11 $ 591,380 $ (475,969) $ 115,422 $ 185 $ 115,607
Balance (in Shares) at Dec. 31, 2023 105,507 205